Geron
GERN
#6219
Rank
โ‚น78.60 B
Marketcap
โ‚น123.14
Share price
-2.16%
Change (1 day)
-62.38%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -โ‚น3.97 Billion

According to Geron's latest financial reports the company's current earnings are โ‚น0.18 Billion. In 2024 the company made an earning of -โ‚น14.14 Billion, an increase over its 2023 earnings that were of -โ‚น15.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น3.97 Billion-71.94%
2024 -โ‚น14.14 Billion-11.23%
2023 -โ‚น15.92 Billion30.22%
2022 -โ‚น12.23 Billion20.15%
2021 -โ‚น10.18 Billion50.08%
2020 -โ‚น6.78 Billion4.46%
2019 -โ‚น6.5 Billion130.68%
2018 -โ‚น2.82 Billion8.84%
2017 -โ‚น2.59 Billion-3.08%
2016 -โ‚น2.67 Billion-22080.6%
2015 โ‚น12.13 M-100.38%
2014 -โ‚น3.23 Billion-7.14%
2013 -โ‚น3.47 Billion
2011 -โ‚น8.21 Billion19.04%
2010 -โ‚น6.9 Billion8.45%
2009 -โ‚น6.36 Billion-2.51%
2008 -โ‚น6.53 Billion14.65%
2007 -โ‚น5.69 Billion32.68%
2006 -โ‚น4.29 Billion25.59%
2005 -โ‚น3.42 Billion4.36%
2004 -โ‚น3.28 Billion19.73%
2003 -โ‚น2.74 Billion-15.46%
2002 -โ‚น3.24 Billion1.94%
2001 -โ‚น3.18 Billion33.59%
2000 -โ‚น2.38 Billion27.53%
1999 -โ‚น1.87 Billion63.13%
1998 -โ‚น1.15 Billion15.6%
1997 -โ‚น0.99 Billion-10.66%
1996 -โ‚น1.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น0.86 Billion-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น895.11 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น10.46 B-351.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น143.80 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น6.27 Billion 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA